A

AtriCure
D

ATRC

31.140
USD
-1.77
(-5.38%)
Market Closed
Volume
17,692
EPS
-1
Div Yield
-
P/E
-33
Market Cap
1,522,110,869
Related Instruments
ABT
ABT
-7.200
(-5.47%)
124.470 USD
BDX
BDX
-15.835
(-7.15%)
205.750 USD
BSX
BSX
-8.780
(-8.92%)
89.700 USD
EW
EW
-3.610
(-4.95%)
69.370 USD
ISRG
ISRG
-41.50
(-8.39%)
451.39 USD
JNJ
JNJ
-5.930
(-3.71%)
153.210 USD
MDT
MDT
-4.750
(-5.41%)
82.870 USD
PFE
PFE
-1.250
(-5.15%)
22.990 USD
RMD
RMD
-8.210
(-3.85%)
205.140 USD
SYK
SYK
-21.51
(-5.84%)
345.93 USD
TMO
TMO
-31.12
(-6.62%)
437.70 USD
More
News

Title: AtriCure

Sector: Healthcare
Industry: Medical Instruments & Supplies
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct salesforce and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.